Keywords: orphan, drug, status, antizol, europe, european, commission

Orphan drug status for Antizol in Europe

Article | 15 June 2001

Print This

The European Commission has granted orphan drug status to OrphanMedical's fomepizole formulation, which is marketed in the USA as Antizol, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in